At the 2019 ASCO Advocacy Summit, ASCO members from 35 states held more than 160 Congressional meetings, urging Members of Congress to take action to advance policy priorities which improve patient access to cancer care, including clinical trials.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
ASCO Board Member Blase N. Polite, MD, MPA, FASCO, provided a keynote address to the European Cancer Summit on September 14 that was written up in The Parliament Magazine.
A new study in the Journal of Oncology Practice (JOP) comparing the use of subacute rehabilitation (SAR) instead of hospice referral since the availably of immunotherapy finds a growing number of people with cancer are being discharged to SAR, but approximately two-thirds do not receive further cancer therapy at any point. This research provides important insights for goals of care.
A new JCO Clinical Cancer Informatics (JCO CCI) article highlights the challenges in and need for obtaining real-world evidence (RWE) for assessing the effectiveness of precision medicine therapies on areas such as survival, quality of life, costs, and health disparities. RWE can be difficult to obtain because of the ways in which data is entered into electronic health records; one proposed solution is the mCODE™ initiative.
Four abstracts are being featured in the press program for the 2019 Quality Care Symposium, which takes place September 6–7 in San Diego.
ASCO is seeking medical institutions in low- and middle-income countries (LMIC) in the Asia-Pacific region to organize one or two live educational courses per year as part of the Society’s International Cancer Corps (ICC). The request for proposals (RFP) process is now open, and all proposals are due December 1.
ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to the agency’s Request for Information (RFI) on Patients over Paperwork. ASCO’s comments provide the society’s perspective on improving the delivery of cancer care in a way that is beneficial for people with cancer and oncology professionals.
ASCO, CancerLinQ LLC and its technology collaborator Concerto HealthAI, and data from the practices that participate in the CancerLinQ® platform will be a part of the upcoming “8th Annual Blueprint for Breakthrough Forum—Validating Real-World Endpoints for an Evolving Regulatory Landscape” forum hosted by Friends of Cancer Research on September 18 in Washington, D.C.
Applications are now open for grant funding for 10 oncology practices in rural or urban centers in the U.S. that primarily treat underserved populations to participate in ASCO’s Quality Oncology Practice Initiative (QOPI®) and Quality Training Program offerings for a three-year period. The generous grant for more than $600,000 has been provided by the Stavros Niarchos Foundation, and it will fund each practice’s training and participation.
Applications are now open for oncology practices in 11 specific U.S. urban centers with high proportions of African-American patients with breast cancer to participate in ASCO’s Quality Oncology Practice Initiative (QOPI®), QOPI® Certification, and Quality Training Program (QTP). Susan G. Komen® is providing training and funding support.
The first practice outside of the U.S. to achieve Quality Oncology Practice Initiative (QOPI®) Certification, Contemporary Oncology Team of Athens, Greece, is now the first to be re-certified.
On November 14, the Fundación ECO para la Excelencia y la Calidad de la Oncología (ECO) will host a one-day Quality Training Program (QTP) workshop at the Hotel Riu Plaza España in Madrid, Spain. Registration for the workshop is now open.
Twenty practices in three countries elevated their standard of care and achieved ASCO's Quality Oncology Practice Initiative (QOPI®) Certification in the second quarter of this year.
ASCO is seeking 10 oncology practices in rural or urban centers in the U.S. that primarily treat underserved populations to participate in its Quality Oncology Practice Initiative (QOPI®) and Quality Training Program (QTP) offerings for a three-year period, with training and funding support provided.
The American Medical Association’s (AMA) House of Delegates (HOD) successfully passed three resolutions that were led by the ASCO delegation during their recent Annual Meeting, as well as a resolution calling on the Centers for Medicare & Medicaid Services to ensure additional patient protections for step therapy in Medicare Advantage this plan year. The HOD also reaffirmed existing policy stating that physicians who have proven adherence to high quality clinical pathways physicians should be exempt from prior authorization requirements.